共 43 条
- [1] A database of [18F]-altanserin binding to 5-HT2A receptors in normal volunteers:: normative data and relationship to physiological and demographic variables[J]. Adams, KH;Pinborg, LH;Svarer, C;Hasselbalch, SG;Holm, S;Haugbol, S;Madsen, K;Frokjær, V;Martiny, L;Paulson, OB;Knudsen, GM. NEUROIMAGE, 2004(03)
- [2] Quantification of PET studies with the very high-affinity dopamine D2/D3 receptor ligand [11C]FLB 457:: re-evaluation of the validity of using a cerebellar reference region[J]. Asselin, Marie-Claude;Montgomery, Andrew J.;Grasby, Paul M.;Hume, Susan P. JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM, 2007(02)
- [3] Serotonin in fear conditioning processes[J]. Bauer, Elizabeth P. BEHAVIOURAL BRAIN RESEARCH, 2015
- [4] Aripiprazole Augmentation in Major Depressive Disorder: A Double-Blind, Placebo-Controlled Study in Patients with Inadequate Response to Antidepressants[J]. Berman, Robert M.;Fava, Maurizio;Thase, Michael E.;Trivedi, Madhukar H.;Swanink, Rene;McQuade, Robert D.;Carson, William H.;Adson, David;Taylor, Leslie;Hazel, James;Marcus, Ronald N. CNS SPECTRUMS, 2009(04)
- [5] Variation in Dopamine D2 and Serotonin 5-HT2A Receptor Genes is Associated with Working Memory Processing and Response to Treatment with Antipsychotics[J]. Blasi, Giuseppe;Selvaggi, Pierluigi;Fazio, Leonardo;Antonucci, Linda Antonella;Taurisano, Paolo;Masellis, Rita;Romano, Raffaella;Mancini, Marina;Zhang, Fengyu;Caforio, Grazia;Popolizio, Teresa;Apud, Jose;Weinberger, Daniel R.;Bertolino, Alessandro. NEUROPSYCHOPHARMACOLOGY, 2015(07)
- [6] A systematic review: antipsychotic augmentation with treatment refractory obsessive-compulsive disorder[J]. Bloch, M. H.;Landeros-Weisenberger, A.;Kelmendi, B.;Coric, V.;Bracken, M. B.;Leckman, J. F. MOLECULAR PSYCHIATRY, 2006(07)
- [7] Opponency Revisited: Competition and Cooperation Between Dopamine and Serotonin[J]. Boureau, Y-Lan;Dayan, Peter. NEUROPSYCHOPHARMACOLOGY, 2011(01)
- [8] THE DISTRIBUTION OF 5-HT1A AND 5-HT2A RECEPTOR MESSENGER-RNA IN HUMAN BRAIN[J]. BURNET, PWJ;EASTWOOD, SL;LACEY, K;HARRISON, PJ. BRAIN RESEARCH, 1995(01)
- [9] Aβ(1-42) injection causes memory impairment, lowered cortical and serum BDNF levels, and decreased hippocampal 5-HT2A levels[J]. Christensen, R.;Marcussen, A. B.;Woertwein, G.;Knudsen, G. M.;Aznar, S. EXPERIMENTAL NEUROLOGY, 2008(01)
- [10] Modulation of striatal dopamine release by 5-HT2A and 5-HT2C receptor antagonists:: [11C] raclopride PET studies in the rat[J]. Egerton, Alice;Ahmad, Rabia;Hirani, Ella;Grasby, Paul M. PSYCHOPHARMACOLOGY, 2008(04)